Complement factor H and susceptibility to major depressive disorder in Han Chinese

British Journal of Psychiatry

Volumn 208, Issue 5, 2016, Pages 446-452

  Chen, Zhang ^a,b   Deng Feng, Zhang ^b   Zhi Guo, Wu ^a   Dai Hui, Peng ^a   Jun, Chen ^a   Jianliang, Ni ^c   Wenxin, Tang ^d   Lin, Xu ^b,e   Yong Gang, Yao ^b,e   Yi Ru, Fang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c Tongde hospital of Zhejiang province   (China)

^d HANGZHOU SEVENTH PEOPLE S HOSPITAL   (China)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; GENOMIC DNA; MESSENGER RNA; COMPLEMENT FACTOR H, HUMAN;

ALLELE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL ANALYSIS; ADULT; CHINA; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

ADULT; AGE OF ONSET; CHINA; COMPLEMENT FACTOR H; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED;

EID: 84973518089     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.115.163790     Document Type: Article

References (43)

1. Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001- 05: an epidemiological survey. Lancet 2009; 373: 2041-53.
2. Wilde A, Mitchell PB, Meiser B, Schofield PR. Implications of the use of genetic tests in psychiatry, with a focus on major depressive disorder: a review. Depress Anxiety 2013; 30: 267-75.
3. Arroyo C, Hu FB, Ryan LM, Kawachi I, Colditz GA, Speizer FE, et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 129-33.
4. Everson SA, Goldberg DE, Kaplan GA, Julkunen J, Salonen JT. Anger expression and incident hypertension. Psychosom Med 1998; 60: 730-5.
5. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch Intern Med 2000; 160: 1261-8.
6. Hepgul N, Cattaneo A, Zunszain PA, Pariante CM. Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Med 2013; 11: 28.
7. Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 2011; 24: 519-25.
8. Yi Z, Li Z, Yu S, Yuan C, Hong W, Wang Z, et al. Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. PLoS One 2012; 7: e31283.
9. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 1997; 66: 1-11.
10. Inoue H, Mashimo Y, Funamizu M, Shimojo N, Hasegawa K, Hirota T, et al. Association study of the C3 gene with adult and childhood asthma. J Hum Genet 2008; 53: 728-38.
11. Ripoche J, Day AJ, Harris TJ, Sim RB. The complete amino acid sequence of human complement factor H. Biochem J 1988; 249: 593-602.
12. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 2010; 128: 349-58.
13. Adams MKM, Simpson JA, Richardson AJ, Guymer RH, Williamson E, Cantsilieris S, et al. Can genetic associations change with age? CFH and age-related macular degeneration. Human Molecular Genetics 2012; 21: 5229-36.
14. Yang XB, Sun JL, Gao Y, Tan AH, Zhang HY, Hu YL, et al. Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects. Plos Genet 2012; 8: e1002916.
15. Baron M. Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 2002; 7: 342-58.
16. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-9.
17. Yuan DQ, Yang Q, Liu XY, Yuan DL, Yuan ST, Xie P, et al. Complement factor H Val62Ile variant and risk of age-related macular degeneration: a meta-analysis. Molecular Vision 2013; 19: 374-83.
18. Jivraj J, Jivraj I, Tennant M, Rudnisky C. Prevalence and impact of depressive symptoms in patients with age-related macular degeneration. Can J Ophthalmol 2013; 48: 269-73.
19. Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci 2013; 5: 56.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
21. Li Z, Zhang C, Fan J, Yuan C, Huang J, Chen J, et al. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study. Br J Psychiatry 2014; 205: 29-35.
22. Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, et al. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. J Clin Psychopharmacol 2011; 31: 638-42.
23. Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, et al. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. J Clin Psychopharmacol 2010; 30: 357-64.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders: Research Version, Patient Edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institute, 2001.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) ( DSM-IV). APA, 1994.
26. Zhang DF, Wang D, Li YY, Yao YG. Mapping genetic variants in the CFH gene for association with leprosy in Han Chinese. Genes Immun 2014; 15: 506-10.
27. Chen H, Liu K, Chen LJ, Hou P, Chen W, Pang CP. Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Mol Vis 2012; 18: 816-29.
28. Huang L, Li Y, Guo S, Sun Y, Zhang C, Bai Y, et al. Different hereditary contribution of the CFH Gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han People. Invest Ophthalmol Vis Sci 2014; 55: 2534-8.
29. Holland MM, Parson W. GeneMarker(R) HID: a reliable software tool for the analysis of forensic STR data. J Forensic Sci 2011; 56: 29-35.
30. Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 2014; 17: 1418-28.
31. Ansari M, McKeigue PM, Skerka C, Hayward C, Rudan I, Vitart V, et al. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration. Hum Mol Genet 2013; 22: 4857-69.
32. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 2005; 10: 6-13.
33. Power RA, Keers R, Ng MY, Butler AW, Uher R, Cohen-Woods S, et al. Dissecting the genetic heterogeneity of depression through age at onset. Am J Med Genet B 2012; 159B: 859-68.
34. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-9.
35. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004; 41: 355-67.
36. Chen H, Yu KD, Xu GZ. Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis. PLoS One 2012; 7: e42464.
37. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 2011; 43: 1232-6.
38. Hasler G, Northoff G. Discovering imaging endophenotypes for major depression. Mol Psychiatry 2011; 16: 604-19.
39. Jonsen A, Nilsson SC, Ahlqvist E, Svenungsson E, Gunnarsson I, Eriksson KG, et al. Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res Ther 2011; 13: R206.
40. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephro 2010; 5: 1844-59.
41. Donoso LA, Vrabec T, Kuivaniemi H. The role of complement factor H in age-related macular degeneration: a review. Surv Ophthalmol 2010; 55: 227-46.
42. Frank MG, Frank JLW, Hendricks SE, Burke WJ, Johnson DR. Age at onset of major depressive disorder predicts reductions in NK cell number and activity. J Affect Disorders 2002; 71: 159-67.
43. Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, et al. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry 2005; 10: 598-605.